GETTING MY RAW MATERIALS TO WORK

“The present problem has exposed some structural weaknesses within the EU’s medicines offer chain in addition to a higher dependence on non-EU nations around the world for active pharmaceutical ingredients,” Kyriakides mentioned. She advisable that supply chain issues be tackled within an EU pharmaceutical approach envisioned to generally be